NJ MSSP
Michele Fronckiewicz
ACO Executive Director
Location
Location

Aledade Accountable Care 25, LLC
4550 Montgomery Ave, Ste 950
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
AUTUMN RIDGE PRIMARY CARE LLC N
CENTRAL JERSEY INTERNAL MEDICINE ASSOCIATES,PA N
COTLER FAMILY PRACTICE, LLC N
DOMINICK CONDO, MD PA N
FARMINGDALE FAMILY PRACTICE ASSOCIATES LLC N
FIRST CARE MEDICAL GROUP, INC N
HAROLD COTLER N
IMMEDICENTER TOTOWA N
MICHAEL S ROGERS MD PA N
OUR FAMILY PRACTICE N
PARTNERS IN FREEDOM LLC N
PRINCETON MEDICAL GROUP,P.A. N
ROBERT EIDUS, M.D. P.A. N
SEA GIRT MEDICAL ASSOCIATES, PC N
STEPHEN NURKIEWICZ N
Vanguard Medical Group PA N
WOODBRIDGE MEDICAL ASSOCIATES,P.A. N

 

First Name Last Name Member's Voting Power (Expressed as a percentage or number) Membership Type Practice Legal Business Name
George Ambrosio 1 ACO Participant Representative First Care Medical Group Inc
Michael Cascarina 1 ACO Participant Representative Our Family Practice, LLC
Dominick Condo 1 ACO Participant Representative Dominick Condo, MD PA
Harold Cotler 1 ACO Participant Representative Cotler Family Practice LLC
Louis Friedman 1 ACO Participant Representative Woodbridge Medical Associates PA
Michele Fronckiewicz 1 Other Aledade
Leonard Grossman 1 ACO Participant Representative Princeton Medical Group, PA
Thomas McCarrick 1 ACO Participant Representative Vanguard Medical Group PA
Michael Rogers 1 ACO Participant Representative Michael S Rogers, MD PA
Thomas Schwartzer 1 ACO Participant Representative Central Jersey Internal Medicine Associates PA
Kurt von Suskil 1 ACO Participant Representative Sea Girt Medical Associates PC
Susan Maugeri 1 Medicare Beneficiary Representative  N/A
  • ACO Executive: Michele Fronckiewicz
  • Medical Director: Dr. Thomas McCarrick
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson
  • Compliance Committee: Dr. Peter Carrazzone
  • Clinical Guidance Committee: Dr. Josette Palmer
  • A network of individual practices of ACO professionals

  • Second Agreement Period 

    • Performance Year 2020, $ 1,130,835

  • First Agreement Period

    • Performance Year 2019, $0

    • Performance Year 2018, $0

Second Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
2020 Quality Performance Results
ACO#
Measure Name
Rate
ACO Mean
ACO-8
Risk Standardized, All Condition Readmission
14.83
15.07
ACO-38
Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions
45.93
49.50
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
0.77
0.95
ACO-13
Falls: Screening for Future Fall Risk
89.81
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
69.65
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
94.74
81.67
ACO-18
Preventive Care and Screening: Screening for Depression and Follow-up Plan
83.89
71.46
ACO-19
Colorectal Cancer Screening
79.38
72.59
ACO-20
Breast Cancer Screening
77.19
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
77.02
83.37
ACO-40
Depression Remission at Twelve Months
17.95
13.99
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
9.97
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
71.05
72.87

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov 

 

Payment Rule Waivers

Waiver for Payment for Telehealth Services: 

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

 

Fraud and Abuse Waivers